Oncology & Cancer

70-gene signature not cost-effective in breast cancer

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published online Oct. 6 in ...

Oncology & Cancer

Enhancement of chemotherapy by prevention of tumor cell repair

Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy ...

page 8 from 10